CN107961342A - A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof - Google Patents
A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof Download PDFInfo
- Publication number
- CN107961342A CN107961342A CN201810074549.3A CN201810074549A CN107961342A CN 107961342 A CN107961342 A CN 107961342A CN 201810074549 A CN201810074549 A CN 201810074549A CN 107961342 A CN107961342 A CN 107961342A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- hemiplegia
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 44
- 206010019468 Hemiplegia Diseases 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 241000545744 Hirudinea Species 0.000 claims abstract description 14
- 241000258241 Mantis Species 0.000 claims abstract description 14
- 241000521581 Millettia Species 0.000 claims abstract description 14
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 14
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 14
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 14
- 241000270273 Ptyas dhumnades Species 0.000 claims abstract description 14
- 235000008434 ginseng Nutrition 0.000 claims abstract description 14
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 13
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 13
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 13
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 14
- 241000208340 Araliaceae Species 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 4
- 238000007654 immersion Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims description 3
- -1 It is any in granula Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 24
- 230000000694 effects Effects 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 206010008111 Cerebral haemorrhage Diseases 0.000 abstract description 10
- 206010008088 Cerebral artery embolism Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 8
- 201000010849 intracranial embolism Diseases 0.000 abstract description 8
- 230000002490 cerebral effect Effects 0.000 abstract description 7
- 206010036790 Productive cough Diseases 0.000 abstract description 3
- 208000024794 sputum Diseases 0.000 abstract description 3
- 210000003802 sputum Anatomy 0.000 abstract description 3
- 238000005728 strengthening Methods 0.000 abstract description 3
- 206010067482 No adverse event Diseases 0.000 abstract description 2
- 230000000593 degrading effect Effects 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 230000001717 pathogenic effect Effects 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 238000012795 verification Methods 0.000 abstract 1
- 210000003414 extremity Anatomy 0.000 description 12
- 208000002173 dizziness Diseases 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 208000026106 cerebrovascular disease Diseases 0.000 description 8
- 206010033799 Paralysis Diseases 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 210000004556 brain Anatomy 0.000 description 6
- 206010008118 cerebral infarction Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000003387 muscular Effects 0.000 description 6
- 206010008190 Cerebrovascular accident Diseases 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000006011 Stroke Diseases 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000003141 lower extremity Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 208000004929 Facial Paralysis Diseases 0.000 description 4
- 208000004044 Hypesthesia Diseases 0.000 description 4
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 201000007201 aphasia Diseases 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 208000034783 hypoesthesia Diseases 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 235000013547 stew Nutrition 0.000 description 4
- 210000001364 upper extremity Anatomy 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010013952 Dysphonia Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000007542 Paresis Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000006278 hypochromic anemia Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010001580 Albuminuria Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000010473 Hoarseness Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 206010060860 Neurological symptom Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 206010037714 Quadriplegia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000001097 facial muscle Anatomy 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010017585 Gait spastic Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000000386 Hypertensive Intracranial Hemorrhage Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000011644 Neurologic Gait disease Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000010836 blood and blood product Substances 0.000 description 1
- 229940125691 blood product Drugs 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036473 myasthenia Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009278 visceral effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Gastroenterology & Hepatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of Chinese medicine composition for treating hemiplegia, the Chinese medicine composition includes the raw material of following parts by weight:100 150 parts of radix astragali, 5 20 parts of fructus alpiniae oxyphyllae, 10 18 parts of mantis egg-case, 5 15 parts of leech, 8 20 parts of Angelica sinensis, 9 18 parts of zaocys dhumnade, 10 20 parts of peach kernel, 12 18 parts of safflower, 25 40 parts of reticulate millettia, 6 20 parts of rhizoma Gastrodiae, 12 20 parts of ginseng.The invention also discloses a kind of preparation method for the Chinese medicine composition for treating hemiplegia.The Chinese medicine composition for the treatment of hemiplegia provided by the invention, through clinical practice application verification for many years, coordinated strengthens between each raw material, it is curative for effect in terms for the treatment of sequelae for cerebral infraction, cerebral embolism sequela and cerebral hemorrhage sequelae, have no adverse reaction, fill blood, degrading the channel, the effect of strengthening vital QI to eliminate pathogenic factors, dissolving stasis resolving sputum, can reach evident in efficacy, treat both principal and secondary aspect of disease, the effect of difficulty in relapse after healing.In addition, its preparation process is simple and easy to do, application easy to spread.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, and in particular to a kind of Chinese medicine composition for treating hemiplegia and preparation method thereof,
More particularly, to a kind of Chinese medicine composition for treating sequelae for cerebral infraction, cerebral embolism sequela and cerebral hemorrhage sequelae and its
Preparation method.
Background technology
Hemiplegia is called hemiplegia, refers to the dyskinesia of the same side upper and lower extremities, facial muscle and lingualis lower part, is acute brain blood
The common sympton of pipe disease.Although slight hemiplegia patient still can be movable, walk and, often upper limb flexing, lower limb stretch, paralysis
Lower limb make a move draw half circle, this special walking posture, is called hemiplegic gait.Severe patient is often unable to leave the bed, and loses life
Viability.According to the degree of hemiplegia, paresis, incomplete paralysis and pamplegia can be divided into.Paresis:Show as muscular strength decrease, muscular strength
At 4-5 grades, daily life is not influenced generally, imperfection paralysis is compared with paresis weight, and scope is larger, 2-4 grades of muscular strength, pamplegia:Muscular strength 0-1
Level, paralyzed limbs are completely stiff.
Cerebrovascular disease refers to rupture of blood vessel in brain bleeding or thrombosis, caused with cerebral haemorrhage or ischemia injury disease
Shape is one group of disease of main clinical manifestation, including cerebral hemorrhage, cerebral thrombus, cerebral infarction etc., also known as cerebrovas-cularaccident or cerebral apoplexy,
It is commonly called as headstroke.The disease is common in the acute attack of crowd above middle age, and the disturbance of consciousness and quadriplegia can occur for severe patient,
It is to cause human death and disabled principal disease.
During generation acute cerebrovascular disease, because destroying corticocerebral motor area or the conduction path below it, it can all draw
Play quadriplegia and various sequelae, such as hemiplegia, facial muscle, glossolysis, facial paralysis, aphasia.Most brains go out
Blood or Changes of Patients With Cerebrovascular Diseases can all leave different degrees of hemiplegia symptom, and extreme difficulties are caused to patient's daily life.Traditional controls
Treatment method is mainly physical therapy, exercise, acupuncture, massage and massage etc., and not only the course for the treatment of is grown, and curative effect is not notable.
The content of the invention
It is an object of the invention to provide a kind of easy, safe and efficient medicine, to cure because of cerebral infarction, cerebral thrombus, brain
Various sequelae and the Chinese medicine composition of various paralysis and preparation method thereof caused by bleeding, it is existing in the prior art to solve
Problem.
To achieve the above object, the first aspect of the present invention provides a kind of Chinese medicine composition for treating hemiplegia, in described
Drug composition includes the raw material of following parts by weight:100-150 parts of radix astragali, 5-20 parts of fructus alpiniae oxyphyllae, 10-18 parts of mantis egg-case, leech
5-15 parts, 8-20 parts of Angelica sinensis, 9-18 parts of zaocys dhumnade, 10-20 parts of peach kernel, 12-18 parts of safflower, 25-40 parts of reticulate millettia, rhizoma Gastrodiae 6-20
Part, 12-20 parts of ginseng.
Further, the Chinese medicine composition includes the raw material of following parts by weight:115-130 parts of radix astragali, fructus alpiniae oxyphyllae 10-
18 parts, 10-18 parts of mantis egg-case, 8-12 parts of leech, 10-15 parts of Angelica sinensis, 12-18 parts of zaocys dhumnade, 15-20 parts of peach kernel, safflower 12-18
Part, 25-35 parts of reticulate millettia, 12-16 parts of rhizoma Gastrodiae, 12-15 parts of ginseng.
Further, the Chinese medicine composition includes the raw material of following parts by weight:120 parts of radix astragali, 15 parts of fructus alpiniae oxyphyllae, mulberry
15 parts of the egg capsule of a mantis, 10 parts of leech, 15 parts of Angelica sinensis, 15 parts of zaocys dhumnade, 15 parts of peach kernel, 15 parts of safflower, 30 parts of reticulate millettia, 15 parts of rhizoma Gastrodiae,
15 parts of ginseng.
Pharmaceutically acceptable auxiliary material, includes but not limited to disintegrant, lubricant, adhesive, diluent etc..The field of Chinese medicines
Common auxiliary material and regular dosage form can be found in such as《Pharmacy》(sixth version), People's Health Publisher.For the use of customary adjuvant
Amount, those skilled in the art can make choice according to the actual content of bulk pharmaceutical chemicals.
Further, the preparation includes any in pill, granule, tablet, capsule or oral liquid.
The second aspect of the present invention provides a kind of preparation method of the Chinese medicine composition of above-mentioned treatment hemiplegia, the method
Comprise the following steps:
1) each raw material of the corresponding parts by weight after drying is weighed;
2) each raw material is put into pot, addition water makes the water surface not have 1-2 centimetres of powder, and when immersion 1 is small, big fire is boiled, turns
Small fire stewes 1-2h slowly, and filtration, the hot water of 70-80 DEG C of addition, makes the water surface not have 1-2 centimetres of powder in filter residue, and big fire is boiled, turns
Small fire stewes 0.5-1h slowly, and filtration, merges decoction liquor twice, and relative density is the clear of 1.12-1.18 when decoction liquor is concentrated into 60 DEG C
Cream, adds pharmaceutically acceptable auxiliary material and preparation is made.
The third aspect of the present invention provides a kind of preparation method of the Chinese medicine composition of above-mentioned treatment hemiplegia, the method
For:Each raw material of the corresponding parts by weight after drying is weighed, simultaneously ground into end is mixed, is made plus pharmaceutically acceptable auxiliary material
Preparation.
Further, ground into end crosses No. 5 sieves.
The pharmacological property of Chinese medicine used in the present invention is as follows:
Radix astragali:It is sweet in flavor, slightly warm in nature.Enter spleen, lung channel.With tonifying Qi and lifting yang, strengthening exterior and reducing sweat, torr sore myogenic, profit water detumescence
Effect.For treating treatment deficiency of vital energy weak, the sinking of qi of middle-jiao, rush down prolapse of the anus for a long time, uterine bleeding of having blood in stool, exterior deficiency spontaneous perspiration, ulcer is difficult to burst, burst for a long time and does not holds back,
Blood deficiency chlorosis, Heat Diabetes, chronic nephritis, albuminuria, diabetes etc..Modern medicine study shows, radix astragali containing saponin, sucrose,
The various trace elements such as polysaccharide, a variety of amino acid, folic acid and selenium, zinc, copper.There is enhancing body's immunity, liver protection, diuresis, anti-
Aging, resisting stress, decompression and wide antibacterial action.Jishengshenqiwan albuminuria can be eliminated, strengthens myocardial contractive power, is adjusted
Blood-sugar content.Radix astragali can not only coronary artery dilator, improve myocardial blood supply, improve immune function, and cell can be delayed to decline
Old process.
Fructus alpiniae oxyphyllae:Acrid flavour, it is warm-natured.Returns spleen, kidney channel.The effect of saliva being taken the photograph with warming spleen and stopping diarrha, warming up kidney contracting urine controlling nocturnal emission with astringent drugs.For controlling
Deficiency-cold in spleen and stomach is treated, is vomitted, diarrhea, crymodynia in abdomen, the more salivas of mouth, enuresis with renal asthenia, frequent micturition, seminal emission, gonorrhoea.
Mantis egg-case:It is sweet in flavor, salty, it is mild-natured.Return liver and kidney channel.With astringent sperm contracting urine, the effect of tonifying the kidney and support yang.Lost for treating
Smart involuntary emission, enuresis frequent micturition, urine gonorrhoea.
Leech:Taste is salty, bitter, mild-natured;It is poisonous.Return liver warp.With dissipating blood stasis with potent drugs, the effect of promoting menstruation Xiao Disorder.For treating blood
Stasis of blood Amenorrhea, abdominal mass lump in the abdomen, traumatic injury.
Angelica sinensis:It is sweet in flavor, pungent, it is warm-natured.Major function:Replenishing and activating blood, menstruction regulating and pain relieving, relaxes bowel.It is dizzy for blood deficiency chlorosis
Dizzy palpitaition, irregular menstruation, closed dysmenorrhea, asthenia cold abdominalgia, dry constipation of intestines, arthralgia pain due to rheumatism, injury from falling down, ulcer sores.
Zaocys dhumnade:It is sweet in flavor, it is mild-natured.Return liver warp.Major function:Wind-dispelling, dredging collateral, stops convulsion.For rheumatoid arthritis stubborn, numbness is arrested
Contraction, apoplexy facial paralysis, hemiplegia, spasm of twitching, lockjaw, leprosy mange, scrofula malignant sore.
Peach kernel:Major function:Promoting blood circulation, relaxes bowel, relieving cough and asthma.For Amenorrhea, dysmenorrhoea , wei lump in the abdomen lump in the abdomens, fall and flutter
Damage, dry constipation of intestines.
Safflower:Acrid flavour, it is warm-natured.Converge to heart and liver channels.With invigorate blood circulation, the effect of removing blood stasis and analgesics.For treating postpartum blood
Dizzy, stasis of blood, chest impediment and cardialgia, blood product, beats the stasis of blood swell, arthralgia, paralysis due to windstroke, macular eruption being dark-purple, dysmenorrhoea, Amenorrhea.
Reticulate millettia:It is bitter, sweet, it is warm-natured.Return liver and kidney channel.With enriching blood, invigorate blood circulation, the effect of dredging collateral.For treating menstruation not
Adjust, blood deficiency chlorosis, paralysis and numbness, arthralgia pain due to rheumatism.
Rhizoma Gastrodiae:It is sweet in flavor, it is mild-natured.Returns spleen, kidney, liver, courage, the heart channel of Hang-Shaoyin.With ceases wind, the effect of arresting convulsion.For treating dizziness eye
It is black, head wind headache, extremity numbness, hemiplegia, aphasia, infantile epilepsy and convulsions.
Ginseng:Mildly bitter flavor, it is mild-natured.Returns spleen, the heart, lung channel.With tonifying Qi, tonifying spleen, beneficial lung, dredging collateral, prevent prolapse and other effects.
This prescription is suitable for hemiplegia, hemiplegia.In the traditional Chinese medical science, this syndrome is apoplexy sequelae category, and cerebrovascular disease is by rescuing
Control, after conscious, leave sequelae, such as hemiplegia, aphasia, facial paralysis, limb adynamia, disfluency, headache
Dizziness, or with brothers' edema.Sallow complexion, or it is dim it is simple and unadorned, tongue is thin white, pale tongue is purple or tongue body not just, thready and hesitant pulse is powerless etc..
The traditional Chinese medical science thinks that positive unsaturated vapor worn with age, kidney qi virtual loss, feelings will is not smooth, five excessive emotional activities, eating and drinking without temperance, and weather is dashed forward
Under the effect of the factors such as change, the imbalance of viscera function negative and positive of qi and blood, qi-movement disturbance, wind fire phlegm-blood stasis void is interlaced, horizontal to alter channels and collaterals, upper illiteracy
Clear key, the serial pathological change caused by numbness resistance brain network.Its interpretation of the cause, onset and process of an illness is in visceral dysfunction, mainly negative and positive disequilibrium, kidney
Dirty function deficiency, qi-movement disturbance phlegm-blood stasis impatency.Acute stage, is based on wind fire phlegm;Sequela stage, empty to be common with phlegm-blood stasis, sick position exists
" brain " old complaint belongs to the disease of asthenia in origin and asthenia in superficiality and simulataneous insufficiency and excessive at " kidney ", disease this in kidney deficiency.It is marked on phlegm-blood stasis.Therefore qi and activate blood circulation resolving sputum,
It is to treat this sick key that eliminating blood stasis and smoothing collaterals, which are had one's ideas straightened out,.
The invention has the advantages that:
It is provided by the invention treatment hemiplegia Chinese medicine composition, it is specific selection radix astragali, fructus alpiniae oxyphyllae, mantis egg-case, leech, when
Return, zaocys dhumnade, peach kernel, safflower, reticulate millettia, rhizoma Gastrodiae and ginseng, and be made with specific ratio, tested through clinical practice application for many years
Demonstrate,prove, coordinated strengthens between each raw material, is treated in terms for the treatment of sequelae for cerebral infraction, cerebral embolism sequela and cerebral hemorrhage sequelae
The effect of effect is definite, has no adverse reaction, fills blood, degrading the channel, strengthening vital QI to eliminate pathogenic factors, dissolving stasis resolving sputum, can reach evident in efficacy, mark
This is simultaneous to control, the effect of difficulty in relapse after healing.In addition, its preparation process is simple and easy to do, application easy to spread.
Embodiment
Following embodiments are used to illustrate the present invention, but are not limited to the scope of the present invention.
Embodiment 1
A kind of Chinese medicine composition for treating hemiplegia, includes the raw material of following parts by weight:115 parts of radix astragali, 18 parts of fructus alpiniae oxyphyllae,
10 parts of mantis egg-case, 8 parts of leech, 20 parts of Angelica sinensis, 12 parts of zaocys dhumnade, 10 parts of peach kernel, 16 parts of safflower, 30 parts of reticulate millettia, 6 parts of rhizoma Gastrodiae,
18 parts of ginseng.
The preparation method of above-mentioned Chinese medicine composition is:
1) each raw material of the corresponding parts by weight after drying is weighed;
2) each raw material is put into pot, addition water makes the water surface not have 2 centimetres of powder, and when immersion 1 is small, big fire is boiled, turns small
Fiery 1h stewed slowly, filtration, the hot water of 70 DEG C of addition, makes the water surface not have 1 centimetre of powder, big fire is boiled, turns small fire and stewes slowly in filter residue
0.5h, filtration, merges decoction liquor twice, and relative density is 1.12 clear cream when decoction liquor is concentrated into 60 DEG C, and addition pharmaceutically may be used
Pill is made in the auxiliary material of receiving.
Embodiment 2
A kind of Chinese medicine composition for treating hemiplegia, includes the raw material of following parts by weight:150 parts of radix astragali, 10 parts of fructus alpiniae oxyphyllae,
15 parts of mantis egg-case, 5 parts of leech, 15 parts of Angelica sinensis, 18 parts of zaocys dhumnade, 12 parts of peach kernel, 15 parts of safflower, 35 parts of reticulate millettia, 12 parts of rhizoma Gastrodiae,
20 parts of ginseng.
The preparation method of above-mentioned Chinese medicine composition is:
1) each raw material of the corresponding parts by weight after drying is weighed;
2) each raw material is put into pot, addition water makes the water surface not have 1.5 centimetres of powder, and when immersion 1 is small, big fire is boiled, turns
Small fire stewes 2h slowly, and filtration, the hot water of 80 DEG C of addition, makes the water surface not have 1 centimetre of powder, big fire is boiled, and it is slow to turn small fire in filter residue
1h is stewed, filtration, merges decoction liquor twice, and relative density is 1.18 clear cream when decoction liquor is concentrated into 60 DEG C, and addition pharmaceutically may be used
Oral liquid is made in the auxiliary material of receiving.
Embodiment 3
A kind of Chinese medicine composition for treating hemiplegia, it is characterised in that the Chinese medicine composition includes following parts by weight
Raw material:It is 120 parts of radix astragali, 15 parts of fructus alpiniae oxyphyllae, 15 parts of mantis egg-case, 10 parts of leech, 15 parts of Angelica sinensis, 15 parts of zaocys dhumnade, 15 parts of peach kernel, red
Spend 15 parts, 30 parts of reticulate millettia, 15 parts of rhizoma Gastrodiae, 15 parts of ginseng.
The preparation method of above-mentioned Chinese medicine composition is:Each raw material of the corresponding parts by weight after drying is weighed, mixes simultaneously powder
End is broken into, No. 5 sieves is crossed, granule is made plus pharmaceutically acceptable auxiliary material.
Embodiment 4
A kind of Chinese medicine composition for treating hemiplegia, includes the raw material of following parts by weight:100 parts of radix astragali, 20 parts of fructus alpiniae oxyphyllae,
12 parts of mantis egg-case, 12 parts of leech, 10 parts of Angelica sinensis, 16 parts of zaocys dhumnade, 18 parts of peach kernel, 18 parts of safflower, 40 parts of reticulate millettia, rhizoma Gastrodiae 20
Part, 12 parts of ginseng.
The preparation method of above-mentioned Chinese medicine composition is:Each raw material of the corresponding parts by weight after drying is weighed, mixes simultaneously powder
End is broken into, No. 5 sieves is crossed, capsule is made plus pharmaceutically acceptable auxiliary material.
Embodiment 5
A kind of Chinese medicine composition for treating hemiplegia, includes the raw material of following parts by weight:130 parts of radix astragali, 5 parts of fructus alpiniae oxyphyllae,
18 parts of mantis egg-case, 15 parts of leech, 8 parts of Angelica sinensis, 9 parts of zaocys dhumnade, 20 parts of peach kernel, 12 parts of safflower, 25 parts of reticulate millettia, 15 parts of rhizoma Gastrodiae,
15 parts of ginseng.
The preparation method of above-mentioned Chinese medicine composition is:Each raw material of the corresponding parts by weight after drying is weighed, mixes simultaneously powder
End is broken into, No. 5 sieves is crossed, tablet is made plus pharmaceutically acceptable auxiliary material.
Test example
In order to show the Chinese medicine composition of the present invention to sequelae for cerebral infraction, cerebral embolism sequela and cerebral hemorrhage sequelae
The therapeutic effect of hemiplegia symptom, the present invention have carried out following clinical trial.
1st, patient data
The patient 526 for being diagnosed as apoplexy sequela for carrying out our hospital's treatment in the past 10 years is chosen, wherein, after cerebral infarction
Disease patient 283 is lost, cerebral embolism sequela patient 167, cerebral hemorrhage sequelae patient 76, the course of disease is 1 month to 15 years, man
Property totally 327, women be 199, the age be 45-75 Sui, average age be 58.1 years old.Symptoms include hemiplegia or hemianesthesia,
Slobbering, dispute is crooked, aphasia etc..
2nd, efficacy assessment standard
Cure:Neurological symptom and Signs disappear substantially, and the limb function of hemiplegia side recovers preferable, and life can be certainly
Reason, being capable of independent ambulation;
Improve:Neurological symptom and Signs largely disappear, and the limb function of hemiplegia side has greatly improved, and support can
Stand, can't take care of oneself, Myodynamia recovery is to 4 grades;
It is invalid:Nothing is substantially change after treatment, or symptom and Signs aggravate after treatment.
3rd, treatment method
The Chinese medicinal composition granules of the oral obtained treatment hemiplegia of the embodiment of the present invention 3, nine grams every time, three times a day,
Surrounding is as a treatment course, and curative effect is observed after 6 courses for the treatment of.
4th, result
526 patients after 6 course of therapy, wherein, in sequelae for cerebral infraction patient, cure 243 people, improve 22 people,
Invalid 18 people;In cerebral embolism sequela patient, 143 people are cured, improve 12 people, invalid 12 people;In cerebral hemorrhage sequelae patient, control
More 64 people, improve 8 people, invalid 4 people.Cure rate is up to 85.6%, and total effective rate is up to 93.5%.
Chinese medicine composition provided by the invention have dispelling, collateral-activating, removing blood stasis and promoting blood circulation the effect of, to treatment sequelae for cerebral infraction,
Hemiplegia, hemiplegia caused by cerebral embolism sequela and cerebral hemorrhage sequelae, have significant curative effect, no pair especially for salivation
Act on, treat both principal and secondary aspect of disease, positive effect.
In above-mentioned clinical test, patient is done using the blood urine routine before and after composition, hepatic and renal function, electrocardiogram etc.
Check and record details, contrast is no abnormal, it is seen that the Chinese medicine composition has no toxic side effect.Using after 1 year to above-mentioned case
Paid a return visit, no patients with recurrent.
Typical case
1st, Lee, man, 59 years old, because of dizziness, hoarseness, and it is powerless to our hospital with left limb, through CT and the traditional Chinese medical science
Inspection comprehensive diagnos is multiple cerebral infarction sequelae.Oral liquid made of oral embodiment 2, twice a day, 400 in the least every time
Rise, surrounding is as a treatment course, dizzy after a course for the treatment of, and hoarseness and the powerless symptom of suffering limb are clearly better, and continue to take 2
Patient recovers normal after the course for the treatment of.
2nd, Mr. Wang, male, 83 years old, because of dizziness headache, the upper and lower myasthenia of limbs in right side, went to a doctor, through CT and the traditional Chinese medical science for 1 week with dysfunction
Inspection comprehensive diagnos is multiple cerebral infarction sequelae.Pill (auxiliary material is honey) made of oral embodiment 1, three times a day,
Each in the morning, afternoon and evening once surrounding is as a treatment course, and after a course for the treatment of, dizziness headache and the powerless symptom of suffering limb have been alleviated;Continue to take
After two courses for the treatment of, right side upper and lower extremities muscular strength, Muscle tensility slightly weaken, and 4 grades of muscular strength, left hand held object obstacle is clearly better;Continue
Patient recovers normal after taking three courses for the treatment of.
3rd, Liu, female, 61 years old, go to a doctor when, family members generation tell its left side facial paralysis, dysphonia, right side limb activity by
Limit, pale complexion, checks that comprehensive diagnos is cerebral embolism sequela through CT and the traditional Chinese medical science.Tablet made of oral embodiment 5, daily three
Secondary, in the morning, afternoon and evening respectively once, surrounding is as a treatment course, and after three courses for the treatment of, language is slightly unfavorable, and limb function substantially recovers;Continue to take
With 5 courses for the treatment of, lamprophonia, limb function recovers normal, takes care of oneself.
4th, Yao, man, 56 years old, because post operation of hypertensive cerebral hemorrhage bleeding is dizzy, headache, left side upper and lower extremities limitation of activity, glossolalia,
Check that comprehensive diagnos is cerebral hemorrhage sequelae through CT and the traditional Chinese medical science, through carrying out my treat-and-release, take orally the granule of embodiment 3, daily
Three times, in the morning, afternoon and evening it is each once, surrounding is as a treatment course, and after two courses for the treatment of, above-mentioned symptom is clearly better, and CT examination encephaledema has disappeared
Lose.
Although above with general explanation and specific embodiment, the present invention is described in detail, at this
On the basis of invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Therefore,
These modifications or improvements without departing from theon the basis of the spirit of the present invention, belong to the scope of protection of present invention.
Claims (8)
1. a kind of Chinese medicine composition for treating hemiplegia, it is characterised in that the Chinese medicine composition includes the original of following parts by weight
Material:100-150 parts of radix astragali, 5-20 parts of fructus alpiniae oxyphyllae, 10-18 parts of mantis egg-case, 5-15 parts of leech, 8-20 parts of Angelica sinensis, zaocys dhumnade 9-18
Part, 10-20 parts of peach kernel, 12-18 parts of safflower, 25-40 parts of reticulate millettia, 6-20 parts of rhizoma Gastrodiae, 12-20 parts of ginseng.
2. it is according to claim 1 treatment hemiplegia Chinese medicine composition, it is characterised in that the Chinese medicine composition include with
The raw material of lower parts by weight:115-130 parts of radix astragali, 10-18 parts of fructus alpiniae oxyphyllae, 10-18 parts of mantis egg-case, 8-12 parts of leech, Angelica sinensis 10-
15 parts, 12-18 parts of zaocys dhumnade, 15-20 parts of peach kernel, 12-18 parts of safflower, 25-35 parts of reticulate millettia, 12-16 parts of rhizoma Gastrodiae, ginseng 12-
15 parts.
3. it is according to claim 1 treatment hemiplegia Chinese medicine composition, it is characterised in that the Chinese medicine composition include with
The raw material of lower parts by weight:120 parts of radix astragali, 15 parts of fructus alpiniae oxyphyllae, 15 parts of mantis egg-case, 10 parts of leech, 15 parts of Angelica sinensis, zaocys dhumnade 15
Part, 15 parts of peach kernel, 15 parts of safflower, 30 parts of reticulate millettia, 15 parts of rhizoma Gastrodiae, 15 parts of ginseng.
4. the Chinese medicine composition of the treatment hemiplegia according to any one of claim 1-3 claim, it is characterised in that institute
It is to add preparation made of pharmaceutically acceptable auxiliary material to state Chinese medicine composition.
5. it is according to claim 4 treatment hemiplegia Chinese medicine composition, it is characterised in that the preparation include pill,
It is any in granula, tablet, capsule or oral liquid.
A kind of 6. preparation method of the Chinese medicine composition of the treatment hemiplegia described in claim 1, it is characterised in that the method bag
Include following steps:
1) each raw material of the corresponding parts by weight after drying is weighed;
2) each raw material is put into pot, addition water makes the water surface not have 1-2 centimetres of powder, and when immersion 1 is small, big fire is boiled, turns small fire
Slowly stewed 1-2h, filtration, the hot water of 70-80 DEG C of addition, makes the water surface not have 1-2 centimetres of powder, big fire is boiled, turns small fire in filter residue
Slowly stewed 0.5-1h, filtration, merges decoction liquor twice, and relative density is the clear cream of 1.12-1.18 when decoction liquor is concentrated into 60 DEG C, is added
Enter pharmaceutically acceptable auxiliary material and preparation is made.
A kind of 7. preparation method of the Chinese medicine composition of the treatment hemiplegia described in claim 1, it is characterised in that the method
For:Each raw material of the corresponding parts by weight after drying is weighed, simultaneously ground into end is mixed, is made plus pharmaceutically acceptable auxiliary material
Preparation.
8. the preparation method of the Chinese medicine composition for the treatment of hemiplegia according to claim 7, it is characterised in that ground into end mistake
No. 5 sieves.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810074549.3A CN107961342A (en) | 2018-01-25 | 2018-01-25 | A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810074549.3A CN107961342A (en) | 2018-01-25 | 2018-01-25 | A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107961342A true CN107961342A (en) | 2018-04-27 |
Family
ID=61993507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810074549.3A Pending CN107961342A (en) | 2018-01-25 | 2018-01-25 | A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107961342A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113082191A (en) * | 2021-05-12 | 2021-07-09 | 卢文刚 | Preparation for effectively treating myocardial infarction hemiplegia and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626449A (en) * | 2012-04-20 | 2012-08-08 | 蔡敏泽 | Capsule for treating apoplexy hemiplegia |
CN103656229A (en) * | 2012-09-10 | 2014-03-26 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition for treating stroke sequela |
-
2018
- 2018-01-25 CN CN201810074549.3A patent/CN107961342A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102626449A (en) * | 2012-04-20 | 2012-08-08 | 蔡敏泽 | Capsule for treating apoplexy hemiplegia |
CN103656229A (en) * | 2012-09-10 | 2014-03-26 | 青岛信立德中药技术研究开发有限公司 | Traditional Chinese medicine composition for treating stroke sequela |
Non-Patent Citations (2)
Title |
---|
胡治安: "补阳还五汤加减治疗脑梗塞后遗症心得", 《健康必读杂志》 * |
陕西省中医研究所革委会《医林改错》三结合评注小组: "《《医林改错》评注》", 30 April 1976 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113082191A (en) * | 2021-05-12 | 2021-07-09 | 卢文刚 | Preparation for effectively treating myocardial infarction hemiplegia and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102283999B (en) | Traditional Chinese medicine preparation for treating insomnia | |
CN100435831C (en) | Preparation for treating high blood pressure, high blood fat, obesity, and climacteric syndrome, and preparation method | |
CN102631593B (en) | Preparation method of traditional Chinese medicine lotion for treating oedema lymphangitis | |
CN102949630A (en) | Traditional Chinese medicine composition for treating abdominal distension caused by lack of gastrointestinal motility | |
CN102670776A (en) | Traditional Chinese medicine composition for curing rheumatism | |
CN101979020B (en) | Chinese medicinal preparation for treating high blood pressure | |
CN103830482B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of apoplexy | |
CN103446575B (en) | Medicine for treating gout | |
CN103585585B (en) | A kind of Chinese medicine composition for the treatment of choledocholithiasis and preparation method thereof | |
CN102600434A (en) | Compound mixture for curing cervical vertigo | |
CN107961342A (en) | A kind of Chinese medicine composition for treating hemiplegia and preparation method thereof | |
CN103920102A (en) | Traditional Chinese medicine for treating primary hypotension | |
CN106039152A (en) | Traditional Chinese medicine preparation for treating acute waist sprain | |
CN103768408B (en) | A kind of medicine preventing and treating anal and intestinal disease postoperative pain | |
CN108837010A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating elderly constipation | |
CN103585372B (en) | Traditional Chinese medicine preparation for treating cerebral palsy | |
CN103721028B (en) | One treats anginal medicine and preparation method | |
CN102380010A (en) | Traditional Chinese medicine formula for treating idiopathic edema | |
CN101417080B (en) | Traditional Chinese medicine preparation for treating rheumatic heart disease | |
CN105362596A (en) | Traditional Chinese medicine for treating pulmonary emphysema and preparation method thereof | |
CN105031311B (en) | A kind of Chinese medicine composition for treating cardiovascular and cerebrovascular disease | |
CN103520468B (en) | A kind of Chinese medicine for the treatment of viral myocarditis | |
CN104367862A (en) | Traditional Chinese medicinal composition for treating urethral calculus | |
CN104367896A (en) | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof | |
CN103961603A (en) | Traditional Chinese medicine preparationcapable of reducing blood fat and freeing vessels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180427 |